COVID-19
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Persons who meet the following criteria in the screening survey -Physician working in internal medicine or respiratory medicine -Persons who have experience in the care of more than 20 mild/moderate I COVID-19 patients without risk factors from July to October 2022
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact on clinical practice when an oral antiviral is approved for mild/moderate I patients without risk factors -Prescription intention of an antiviral and their reasons -Expectation to an antiviral in those patient treatments -Impacts on the burden of health care workers | — |
Secondary
| Measure | Time frame |
|---|---|
| Information on the care of mild/moderate I patients without risk factors -Current practice of treatment, Satisfaction of treatment -Degree of pressure on the medical system: Impact on other medical services, lack of personnel -Burden on healthcare workers and their factors: working hours, infection control measures, and infection risk -Impacts when healthcare workers infected | — |
Countries
Japan
Contacts
SHIONOGI & Co., Ltd. Medical Affairs Department